Glen Harbor Capital Management’s Acceleron Pharma XLRN Stock Holding History

Glen Harbor Capital Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$44K	Sell	1,122 -170	-13%	-$7.38K	﹤0.01%	1240
2019 Q2	$53K	Sell	1,292 -9,622	-88%	-$398K	﹤0.01%	1243
2019 Q1	$508K	Sell	10,914 -68	-0.6%	-$2.99K	0.01%	672
2018 Q4	$478K	Sell	10,982 -8,126	-43%	-$406K	0.01%	639
2018 Q3	$1.09M	Sell	19,108 -374	-2%	-$18.4K	0.02%	451
2018 Q2	$945K	Buy	19,482 +2,142	+12%	+$78K	0.02%	452
2018 Q1	$678K	Buy	+17,340	New	+$737K	0.02%	524

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Glen Harbor Capital Management's XLRN Position: Q3 2019 in Review

Glen Harbor Capital Management reduced its Acceleron Pharma (XLRN) stake by 13% in Q3 2019, selling an estimated $7.38K and leaving 1,122 shares worth $44K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Glen Harbor Capital Management first reported a position in XLRN in Q1 2018 and has held it in 7 quarters since. The position peaked at $1.09M in Q3 2018. 172 funds tracked by Wall St. Rank hold XLRN as of Q3 2019.

Glen Harbor Capital Management held 1,122 shares of Acceleron Pharma worth $44K as of Q3 2019.
Glen Harbor Capital Management sold 170 Acceleron Pharma shares in Q3 2019, an estimated $7.38K.
Acceleron Pharma made up ﹤0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #1240 holding.
Glen Harbor Capital Management first reported a position in Acceleron Pharma in Q1 2018 and has held it in 7 quarters since.
Glen Harbor Capital Management's Acceleron Pharma position peaked at $1.09M in Q3 2018.
172 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.